A patient may be aware of the complications that could arise from a lack of adherence with a chronic disease like diabetes, but education is not enough to change a patient’s lifestyle, explained Scott Breidbart, MD, MBA, chief clinical officer of EmblemHealth.
A patient may be aware of the complications that could arise from a lack of adherence with a chronic disease like diabetes, but education is not enough to change a patient’s lifestyle, explained Scott Breidbart, MD, MBA, chief clinical officer of EmblemHealth.
Transcript (slightly modified)
How does the lack of adherence for diabetes add costs in the long run?
—
—
Well that’s very clear that medications have beneficial effects, that’s why we prescribe them. And if patients don’t take the medications, they don’t get the beneficial effects. There are financial costs but far more importantly, there are the costs to our membersblindness, cardiovascular disease, renal failure and amputationsdiabetes is a terrible disease.
Do patients fully understand the complications that could occur from a lack of adherence?
I think all patients have had sufficient education to know the serious effects. Education is not enough to change someone’s lifestyle. I have to admit, I know that I should floss my teeth every day. I know what’s, going to happen in terms of potential gingivitis and periodontal disease and potentially tooth loss but I still don’t do it. I know that I shouldn’t sit as much as I do at the computer and that I should exercise more and I know there are cardiovascular implications to my sitting as much as I do and not exercising as much as I should but I balance that with my lifestyle. I like to earn money to do things that I find fun, so I’m balancing it.
I can’t be surprised that people with diabetes aren’t doing the same thing. Their risks are much higher than mine, because fortunately I don’t have diabetes, but everyone balances his or her lifestyle with what needs to be done to keep his or her health optimal.
Research Points to Potential MCIDs in Diabetes Distress Scale–17
November 29th 2023Researchers identified a value of at least 0.25 to be a minimal clinically important difference (MCID) in diabetes distress, and MCID values of 0.38 and 0.39 for emotional and interpersonal distress subscales and physician and regimen distress subscales, respectively.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Study Reveals Factors That Further Increase Colorectal Cancer Risk for Adults With T2D
November 14th 2023The strongest associations between diabetes and colorectal cancer risk were observed in participants with a recent diabetes diagnosis and those who had not undergone recent colonoscopy, underscoring the significance of cancer screening.
Read More